About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy and Safety Study of XP12B in Women With Menorrhagia

NCT00386308·52 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ferring Pharmaceuticals

Age

18–49

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women with menorrhagia
18-49 years of age
Regularly occurring menstrual periods

You may not be if

History or presence of clinically significant disease or abnormalities that may confound the study
History of bilateral oophorectomy or hysterectomy
Hormone therapy

The record

StatusCompleted

PhasePhase 3

Taking part196

StartedOct 2006

UpdatedMay 4, 2011

Conditions

Menorrhagia Heavy Menstrual Bleeding

Where52

Investigative Site
Tucson, Arizona, United States
Investigative Site
Tucson, Arizona, United States
Investigative Site
Little Rock, Arkansas, United States

Clareo Health | Efficacy and Safety Study of XP12B in Women With Menorrhagia